American Heart Journal
Volume 148, Issue 5 , Pages 789-794 , November 2004

Impaired coronary blood flow in patients with metabolic syndrome: Documented by Thrombolysis In Myocardial Infarction (TIMI) frame count method

  • Hasan Turhan, MD

      Affiliations

    • Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey
    • Corresponding Author InformationReprint requests: Hasan Turhan, MD, Turkocagi caddesi, 20. sokak, No: 2/2 Balgat, Ankara 06520, Turkey.
    • ,
  • Ali Riza Erbay, MD

      Affiliations

    • Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey
    • ,
  • Ayse Saatci Yasar, MD

      Affiliations

    • Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey
    • ,
  • Asuman Bicer, MD

      Affiliations

    • Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey
    • ,
  • Hatice Sasmaz, MD

      Affiliations

    • Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey
    • ,
  • Ertan Yetkin, MD

      Affiliations

    • Department of Cardiology, Inonu University, Malatya, Turkey

Received 5 January 2004 ,Accepted 2 May 2004.

References 

  1. Wilson PWF, Kannel WB, Silbershatz H, et al.  Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–1109
  2. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:25
  3. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998;83:2773–2776
  4. Despres JP, Lamarche B, Mauriege P, et al.  Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952–957
  5. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  6. Harrison DG. Endothelial dysfunction in the coronary microcirculation: a new clinical entity or an experimental finding?. J Clin Invest. 1993;91:1–2
  7. Cosentino F, Luscher TF. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol. 1998;32(Suppl 3):S54–61
  8. Arcaro G, Zamboni M, Rossi L, et al.  Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. Int J Obes Relat Metab Disord. 1999;23:936–942
  9. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium [review]. N Engl J Med. 1990;323:27–36
  10. Gibson CM, Cannon CP, Daley WL, et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–888
  11. Kern MJ, Moore JA, Aguerre FV, et al.  Determination of angiographic (TIMI grade) blood flow by intracoronary Doppler flow velocity during acute myocardial infarction. Circulation. 1996;94:1545–1552
  12. Manginas A, Gatzov P, Chasikidis C, et al.  Estimation of coronary flow reserve using the Thrombolysis In Myocardial Infarction (TIMI) frame count method. Am J Cardiol. 1999;83:1562–1565
  13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  15. Dodge JT, Brown BG, Bolson EL, et al.  Intrathoracic spatial location of specified coronary segments on the normal human heart: application in quantitative arteriography, assessment of regional risk and contraction, and anatomic display. Circulation. 1988;78:1167–1180
  16. Epstein SE, Cannon O, Talbot TL. Hemodynamic principles in the control of coronary blood flow. Am J Cardiol. 1985;56:4
  17. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526
  18. Vanhoutte PM, Rubanyi GM, Miller VM, et al.  Modulation of vascular smooth muscle contraction by the endothelium [review]. Annu Rev Physiol. 1986;48:307–320
  19. Mikhail N, Tuck ML. Insulin and the vasculature. Curr Hypertens Rep. 2000;2:148–153
  20. Steinberg HO, Chaker H, Leaming R, et al.  Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601–2617
  21. Kuboki K, Jiang ZY, Takahara N, et al.  Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation. 2000;101:676–681
  22. Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin: direct measurement in vascular endothelial cells. J Clin Invest. 1996;98:894–898
  23. Steinberg HO, Paradisi G, Hook G, et al.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000;49:1231–1238
  24. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med. 1996;47:365–375
  25. Higashi Y, Oshima T, Sasaki N, et al.  Relationship between insulin resistance and endothelium-dependent vascular relaxation in patients with essential hypertension. Hypertension. 1997;29(1 pt 2):280–285
  26. Balletshofer BM, Rittig K, Enderle MD, et al.  Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation. 2000;101:1780–1784
  27. Zalba G, Beaumont J, San Jose G, et al.  Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem. 2000;56:57–64
  28. Laight DW, Carrier MJ, Anggard EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res. 2000;47:457–464
  29. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes, and heart failure. Cardiovasc Res. 1999;43:562–571
  30. Hamilton CA, Berg G, McIntyre M, et al.  Effects of nitric oxide and superoxide on relaxation in human artery and vein. Atherosclerosis. 1997;133:77–86
  31. Perticone F, Ceravolo R, Candigliota M, et al.  Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Diabetes. 2001;50:159–165
  32. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1996;45:3–10
  33. Jensen MD, Haymond MW, Rizza RA, et al.  Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 1989;83:1168–1173
  34. Arnett EN, Isner JM, Redwood DR, et al.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91:350–356
  35. Chemarin-Alibelli MJ, Pieraggi MT, Elbaz M, et al.  Identification of coronary thrombus after myocardial infarction by intracoronary ultrasound compared with histology of tissues sampled by atherectomy. Am J Cardiol. 1996;77:344–349
  36. Potkin BN, Bartorelli AL, Gessert JM, et al.  Coronary artery imaging with intravascular high-frequency ultrasound. Circulation. 1990;81:1575–1585
  37. St Goar FG, Pinto FJ, Alderman EL, et al.  Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation. 1992;86:756–763

PII: S0002-8703(04)00274-1

doi: 10.1016/j.ahj.2004.05.016

American Heart Journal
Volume 148, Issue 5 , Pages 789-794 , November 2004

Article Tools